What 18 Analyst Ratings Have To Say About Roblox
Roblox (NYSE:RBLX) has observed the following analyst ratings within the last quarter:
What 38 Analyst Ratings Have To Say About Netflix
Over the past 3 months, 38 analysts have published their opinion on Netflix (NASDAQ:NFLX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Where New Relic Stands With Analysts
Within the last quarter, New Relic (NYSE:NEWR) has observed the following analyst ratings:
Where LTC Properties Stands With Analysts
Analysts have provided the following ratings for LTC Properties (NYSE:LTC) within the last quarter:
Jefferies Downgrades CytomX Therapeutics to Hold, Lowers Price Target to $2
Jefferies analyst Roger Song downgrades CytomX Therapeutics (NASDAQ:CTMX) from Buy to Hold and lowers the price target from $12 to $2.
Analyst Ratings for Paychex
Analysts have provided the following ratings for Paychex (NASDAQ:PAYX) within the last quarter:
Analyst Ratings for 1Life Healthcare
Analysts have provided the following ratings for 1Life Healthcare (NASDAQ:ONEM) within the last quarter:
What 4 Analyst Ratings Have To Say About Alkami Technology
Alkami Technology (NASDAQ:ALKT) has observed the following analyst ratings within the last quarter:
Expert Ratings for PPL
Over the past 3 months, 8 analysts have published their opinion on PPL (NYSE:PPL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Analyst Ratings for Intra-Cellular Therapies
Over the past 3 months, 4 analysts have published their opinion on Intra-Cellular Therapies (NASDAQ:ITCI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.